A prognostic signature for lung adenocarcinoma by five genes associated with chemotherapy in lung adenocarcinoma
Xiaofeng Li, Chunwei Xu, Yonghua Min, Zhanqiang Zhai, Youcai Zhu · 2023
Read A prognostic signature for lung adenocarcinoma by five genes associated with chemotherapy in lung adenocarcinoma by Xiaofeng Li, Chunwei Xu, Yonghua Min, Zhanqiang Zhai, Youcai Zhu (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10730453.txt.
Description
Xiaofeng Li and co-authors build, in a 2023 study, a five-gene score that forecasts outcome for patients with the most common type of lung cancer. Genes tied to drug response were the starting pool. Data came from two large public cancer databases, plus a drug sensitivity database.
The team screened genes that differed between tumor and healthy tissue, then kept those tied to survival. Five genes formed the final score. Patients above the score cutoff had clearly worse survival than those below it. The authors present the score as a possible marker to sort patients by risk. Such sorting could help doctors plan follow-up and treatment intensity.
Catalog record
| CREATOR | Xiaofeng Li, Chunwei Xu, Yonghua Min, Zhanqiang Zhai, Youcai Zhu |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |